GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boule Diagnostics AB (OSTO:BOUL) » Definitions » Cyclically Adjusted PS Ratio

Boule Diagnostics AB (OSTO:BOUL) Cyclically Adjusted PS Ratio : 0.43 (As of Jun. 03, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Boule Diagnostics AB Cyclically Adjusted PS Ratio?

As of today (2025-06-03), Boule Diagnostics AB's current share price is kr8.08. Boule Diagnostics AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was kr18.72. Boule Diagnostics AB's Cyclically Adjusted PS Ratio for today is 0.43.

The historical rank and industry rank for Boule Diagnostics AB's Cyclically Adjusted PS Ratio or its related term are showing as below:

OSTO:BOUL' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.37   Med: 1.63   Max: 4.06
Current: 0.43

During the past years, Boule Diagnostics AB's highest Cyclically Adjusted PS Ratio was 4.06. The lowest was 0.37. And the median was 1.63.

OSTO:BOUL's Cyclically Adjusted PS Ratio is ranked better than
86.54% of 483 companies
in the Medical Devices & Instruments industry
Industry Median: 2.19 vs OSTO:BOUL: 0.43

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Boule Diagnostics AB's adjusted revenue per share data for the three months ended in Mar. 2025 was kr2.957. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is kr18.72 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Boule Diagnostics AB Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Boule Diagnostics AB's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boule Diagnostics AB Cyclically Adjusted PS Ratio Chart

Boule Diagnostics AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.00 2.27 0.85 0.60 0.48

Boule Diagnostics AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.53 0.54 0.48 0.48 0.47

Competitive Comparison of Boule Diagnostics AB's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Boule Diagnostics AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boule Diagnostics AB's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boule Diagnostics AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Boule Diagnostics AB's Cyclically Adjusted PS Ratio falls into.


;
;

Boule Diagnostics AB Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Boule Diagnostics AB's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=8.08/18.72
=0.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boule Diagnostics AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Boule Diagnostics AB's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2.957/132.8245*132.8245
=2.957

Current CPI (Mar. 2025) = 132.8245.

Boule Diagnostics AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 2.937 99.995 3.901
201509 3.329 100.228 4.412
201512 3.228 100.276 4.276
201603 3.154 100.751 4.158
201606 3.792 101.019 4.986
201609 4.001 101.138 5.255
201612 3.682 102.022 4.794
201703 3.883 102.022 5.055
201706 4.028 102.752 5.207
201709 4.028 103.279 5.180
201712 3.792 103.793 4.853
201803 3.641 103.962 4.652
201806 3.945 104.875 4.996
201809 4.046 105.679 5.085
201812 3.542 105.912 4.442
201903 4.370 105.886 5.482
201906 4.365 106.742 5.432
201909 4.760 107.214 5.897
201912 4.768 107.766 5.877
202003 4.305 106.563 5.366
202006 3.297 107.498 4.074
202009 3.498 107.635 4.317
202012 3.066 108.296 3.760
202103 4.749 108.360 5.821
202106 3.919 108.928 4.779
202109 4.014 110.338 4.832
202112 5.679 112.486 6.706
202203 4.897 114.825 5.665
202206 4.855 118.384 5.447
202209 4.710 122.296 5.115
202212 4.619 126.365 4.855
202303 3.625 127.042 3.790
202306 3.769 129.407 3.869
202309 3.644 130.224 3.717
202312 3.879 131.912 3.906
202403 3.773 132.205 3.791
202406 3.423 132.716 3.426
202409 3.359 132.304 3.372
202412 3.736 132.987 3.731
202503 2.957 132.825 2.957

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Boule Diagnostics AB  (OSTO:BOUL) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Boule Diagnostics AB Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Boule Diagnostics AB's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Boule Diagnostics AB Business Description

Traded in Other Exchanges
N/A
Address
Domnarvsgatan 4, Spanga, SWE, SE-163 53
Boule Diagnostics AB is a company operating in the diagnostics market. It is engaged in the development, manufacturing and marketing instruments and consumables for blood diagnostics. The firm focuses on the decentralized market segment. The systems are intended for small and medium-sized hospitals, clinics and laboratories within outpatient care. Through its subsidiaries, the Group operates in Sweden, USA, and China.

Boule Diagnostics AB Headlines

No Headlines